12 Recent Findings About Long COVID That Researchers Are Tracking

5. Gastrointestinal Manifestations and Gut Microbiome Changes

Recent research has unveiled significant and persistent gastrointestinal complications associated with Long COVID, revealing the gut as another major target organ affected by SARS-CoV-2 infection. Studies have shown that a substantial percentage of Long COVID patients experience ongoing digestive issues, including chronic diarrhea, constipation, abdominal pain, nausea, and loss of appetite that can persist for months after their initial infection. Advanced research into the gut microbiome – the complex ecosystem of bacteria and other microorganisms that inhabit our digestive tract – has revealed that COVID-19 can cause profound and lasting changes to this crucial biological system. Researchers at the Chinese University of Hong Kong and other institutions have documented significant alterations in gut bacterial composition in Long COVID patients, with reduced diversity and beneficial bacteria alongside increased populations of potentially harmful microorganisms. These microbiome changes appear to correlate with the severity and duration of gastrointestinal symptoms, suggesting a direct relationship between gut bacterial health and Long COVID recovery. Furthermore, scientists have discovered that SARS-CoV-2 can directly infect cells in the gastrointestinal tract through ACE2 receptors, potentially causing ongoing inflammation and tissue damage that contributes to persistent symptoms. The gut-brain axis, a bidirectional communication pathway between the digestive system and the central nervous system, may also play a role in Long COVID, as disruptions to gut health can influence mood, cognition, and overall well-being. These findings have led to clinical trials investigating whether probiotics, dietary interventions, and other gut-targeted therapies might help restore normal digestive function and improve overall outcomes in Long COVID patients.